The estimated Net Worth of Nancy A. Grygiel is at least $4.66 Milion dollars as of 3 May 2024. Ms Grygiel owns over 2,117 units of AMGEN stock worth over $3,261,192 and over the last 4 years she sold AMGN stock worth over $1,395,062.
Ms has made over 4 trades of the AMGEN stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 2,117 units of AMGN stock worth $662,812 on 3 May 2024.
The largest trade she's ever made was exercising 2,500 units of AMGEN stock on 11 May 2021 worth over $406,500. On average, Ms trades about 242 units every 36 days since 2020. As of 3 May 2024 she still owns at least 9,883 units of AMGEN stock.
You can see the complete history of Ms Grygiel stock trades at the bottom of the page.
Nancy A. Grygiel is the Sr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance Officer at AMGEN.
Ms Grygiel is 53, she's been the Sr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance Officer of AMGEN since . There are 21 older and 2 younger executives at AMGEN. The oldest executive at AMGEN Inc. is Fred Hassan, 74, who is the Independent Director.
Nancy's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320.
Over the last 21 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer a Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: